← 返回前沿论文

硒-光热肽组装体双重屏障重塑实体瘤用于 NK 细胞导向免疫治疗

英文原题:Dual-Barrier Remodeling of Solid Tumors by a Selenium-Photothermal Peptide Assembly for NK Cell-Oriented Immunotherapy.

PubMed 2026/08/19(内容时间) Adv Healthc Mater Q1 · IF 11(JCR 2025)

研究概要

这些结果表明,对肿瘤微环境进行协调的物理和免疫重塑,可以提高免疫耐药肿瘤的应答性。

中文摘要

实体瘤中的免疫抵抗由物理排斥和免疫抑制的共存所维持,但能够协同解决这两种屏障的生物材料策略仍然有限。在此,我们报道一种单组分硒-光热肽偶联物 IR820-SFM Se,其可自组装成超分子纳米平台,并协调基质重塑与 HLA-E/Qa-1 检查点调控,用于面向 NK 细胞的癌症免疫治疗。IR820-SFM Se 自组装成纳米级球形结构,并在 808 nm 照射下表现出增强的近红外光热性能。含硒模块下调人乳腺癌细胞中的 HLA-E 和小鼠 4T1 细胞中的 Qa-1,并伴随 NK-92 介导的细胞毒性和炎性细胞因子表达增强。激光照射后,IR820-SFM Se 诱导局部光热加热,触发免疫原性细胞死亡,并改变基质和血管结构。在双侧 4T1 模型中,这种协同策略显著抑制原发瘤和远端瘤,并伴随 NK 细胞活化增强、树突状细胞成熟、T 细胞浸润增加以及全身性 IFN- 和 TNF- 水平升高。这些结果表明,肿瘤微环境的协同物理和免疫重塑可改善免疫抵抗性肿瘤的应答性。我们的研究建立了一个超分子生物材料框架,用于克服实体瘤免疫治疗中的双重屏障。

展开英文摘要原文

Immune resistance in solid tumors is sustained by the coexistence of physical exclusion and immunological suppression, yet biomaterial strategies that coordinately address both barriers remain limited. Here, we report a single-component selenium-photothermal peptide conjugate, IR820-SFM Se , that self-assembles into a supramolecular nanoplatform and coordinates stromal remodeling with HLA-E/Qa-1 checkpoint modulation for NK-cell-oriented cancer immunotherapy. IR820-SFM Se self-assembled into nanoscale spherical structures and displayed enhanced near-infrared photothermal performance under 808 nm irradiation. The selenium-containing module downregulated HLA-E in human breast cancer cells and Qa-1 in murine 4T1 cells, which was accompanied by enhanced NK-92-mediated cytotoxicity and inflammatory cytokine expression. Upon laser irradiation, IR820-SFM Se induced localized photothermal heating, triggered immunogenic cell death, and altered stromal and vascular architecture. In bilateral 4T1 models, this coordinated strategy markedly inhibited both primary and distant tumors, accompanied by enhanced NK-cell activation, dendritic cell maturation, increased T-cell infiltration, and elevated systemic IFN- and TNF- levels. These results demonstrate that coordinated physical and immunological remodeling of the tumor microenvironment can improve the responsiveness of immune-resistant tumors. Our study establishes a supramolecular biomaterial framework for overcoming dual barriers in solid tumor immunotherapy.

论文信息

作者
Peng L、Ji M、Kong Y、Xing W、Wang L、Zheng Z
单位
The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory On Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, China.China
期刊
Advanced healthcare materials2026 Aug 19
原文标识
PubMed 42619319 · DOI 10.1002/adhm.71631